DECIPHERA PHARMACEUTICALS IN's ticker is DCPH and the CUSIP is 24344T101. A total of 144 filers reported holding DECIPHERA PHARMACEUTICALS IN in Q4 2021. The put-call ratio across all filers is 0.15 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $530,000 | -6.2% | 15,593 | +1.0% | 0.00% | 0.0% |
| Q2 2021 | $565,000 | -21.5% | 15,440 | -3.8% | 0.00% | 0.0% |
| Q1 2021 | $720,000 | -26.5% | 16,056 | -6.4% | 0.00% | 0.0% |
| Q4 2020 | $979,000 | -38.7% | 17,157 | -44.9% | 0.00% | -50.0% |
| Q3 2020 | $1,596,000 | -40.5% | 31,115 | -30.7% | 0.00% | -50.0% |
| Q2 2020 | $2,681,000 | -27.8% | 44,894 | -50.2% | 0.00% | +33.3% |
| Q1 2020 | $3,712,000 | +44.0% | 90,180 | +117.8% | 0.00% | 0.0% |
| Q4 2019 | $2,577,000 | +115.8% | 41,399 | +17.7% | 0.00% | +50.0% |
| Q3 2019 | $1,194,000 | +7362.5% | 35,171 | +4867.7% | 0.00% | – |
| Q2 2019 | $16,000 | 0.0% | 708 | 0.0% | 0.00% | – |
| Q1 2019 | $16,000 | +6.7% | 708 | 0.0% | 0.00% | – |
| Q4 2018 | $15,000 | -54.5% | 708 | -16.0% | 0.00% | – |
| Q3 2018 | $33,000 | +13.8% | 843 | +15.2% | 0.00% | – |
| Q2 2018 | $29,000 | -97.5% | 732 | -98.8% | 0.00% | -100.0% |
| Q3 2017 | $1,139,000 | – | 60,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 1,209,571 | $69,030,000 | 15.95% |
| SV Health Investors, LLC | 449,951 | $25,679,000 | 12.37% |
| Sunesis Advisors, LLC | 96,299 | $5,496,000 | 4.45% |
| Redmile Group, LLC | 4,437,968 | $253,275,000 | 3.07% |
| Consonance Capital Management LP | 484,671 | $27,660,000 | 2.58% |
| SECTORAL ASSET MANAGEMENT INC | 488,842 | $27,898,000 | 1.97% |
| Opaleye Management Inc. | 222,000 | $12,670,000 | 1.66% |
| Eversept Partners, LP | 246,240 | $14,052,917 | 1.65% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 38,620 | $2,204,000 | 1.28% |
| Avoro Capital Advisors LLC | 1,300,000 | $74,191,000 | 1.28% |